LW, Pre-Test: HPV Prevention & Treatment in Special Populations: Part 4 of 4 - Frequently Asked Questions

1. HPV Prevention & Treatment in Special Populations: Part 4 of 4 - FAQ Panel, October 31, 2016

Question Title

Please take a minute to complete this pre-session survey to help ARHP assess the impact of its educational programs. Completing this survey will provide ARHP with an invaluable tool for understanding how health professionals use educational offerings and how ARHP activities might be improved to serve you better.

Question Title

* 1. Your primary professional category (choose the one best response):

Health Professional Educator

Nurse Midwife

Nurse Practitioner

Pharmacist

Physician

Physician Assistant

Registered Nurse

Resident

Student

Other (please specify)

Question Title

* 2. Do you interact with patients?

Yes

Question Title

* 3. True or False: Annually, women are diagnosed with higher rates of HPV-associated cancers than men.

True

False

Question Title

* 4. What are the two types of “high-risk” HPV responsible for 80% of cancers?

Types 6 & 11

Types 16 & 18

Types 31 & 33

Types 45 & 52

Question Title

* 5. Jared is 26 and in your office for the first time. He mentions that he started the HPV vaccine series (4-valent) but didn’t get past. Your office has stopped carrying the 4v HPV vaccine, and now only has the 9v HPV vaccine. What do the ACIP guidelines recommend for you to do in this case?

Give the full 3 series of the 9v HPV vaccine

Give a shortened 2 series of the 9v HPV vaccine

Give one shot of the 9v HPV vaccine to complete the series

Refer to a colleague who has some 4v HPV vaccine left over

Question Title

* 6. As a result of participating in this activity, I hope to be better able to:

Thank you for completing this pre-session questionnaire. Please see the reminder e-mail for complete instructions on how to access the webinar. If you have any questions, please contact education@arhp.org.